Olipop Alternatives: The Best Options for Every Use Case
A clinical comparison of Olipop alternatives for gut health, sugar reduction, weight management, and soda replacement. Evidence-based picks with prebiotic fiber data.
PlushCare Overview: Business Model, GLP-1 Access, and Independent Clinical Assessment
An independent, evidence-based overview of PlushCare's telehealth platform, including its business model, GLP-1 prescribing practices, clinical quality indicators, and how it compares to alternatives.
PlushCare Pricing Analysis: Total Cost Breakdown for 2026
Independent pricing analysis of PlushCare telehealth visits, memberships, GLP-1 prescriptions, and hidden costs. Compared against alternatives with cited evidence.
Ro Pricing Analysis: What You Actually Pay for Telehealth Weight Loss, ED, and Hair Loss Treatment
Independent pricing breakdown of Ro's telehealth services including GLP-1 weight loss, erectile dysfunction, hair loss, and mental health programs. Covers total cost, hidden fees, and how Ro compares to competitors.
Who Is Sequence (Now WeightWatchers Clinic) Best For? Ideal Patient Profile
Independent analysis of who benefits most from Sequence, now operating as WeightWatchers Clinic. Covers ideal patient criteria, GLP-1 prescribing, cost, clinical evidence, and how it compares to alternatives.
Shed Best Alternatives for Each Use Case
Independent comparison of Shed and its top alternatives for compounded GLP-1 weight loss, telehealth convenience, cost, and clinical support. Evidence-based analysis with cited sources.
Strut Health Best Alternatives for Each Use Case
An independent comparison of Strut Health alternatives for men's hair loss, ED, and peptides. Evidence-based picks with pricing, prescribing details, and clinical backing.
Talkspace Best Alternatives for Each Use Case
A clinical comparison of Talkspace and its top alternatives for therapy, psychiatry, couples counseling, and medication management, with evidence-based recommendations for each use case.
Thirty Madison Prescription Process: How the Intake Works, What Gets Prescribed, and Whether It's Worth It
An independent clinical review of Thirty Madison's prescription and intake process across Keeps, Cove, Picnic, and Facet. Covers medications prescribed, provider qualifications, cost breakdown, and how the platform compares to alternatives.
What Thorne Misses: Clinical Gaps and Limitations You Should Know
An independent clinical assessment of Thorne supplements, covering prescription gaps, evidence limitations, cost considerations, and what this premium brand cannot replace.
Transcend Alternatives: The Best Options for Every Hormone Optimization Use Case
Independent comparison of Transcend alternatives for testosterone therapy, peptides, thyroid support, and women's HRT. Evidence-based analysis with cost breakdowns and clinical guidance.
TrimRx Prescription Process: How the Intake Works, What You Get, and Whether It's Worth It
An independent breakdown of the TrimRx prescription and intake process for compounded GLP-1 medications, including cost, clinical evidence, safety considerations, and how it compares to alternatives.
TrimRx Pricing Analysis: Total Cost, What You Get, and How It Compares
Independent pricing breakdown of TrimRx compounded GLP-1 programs. We analyze monthly costs, hidden fees, what's included, and how TrimRx stacks up against Hims, Henry Meds, and other telehealth weight-loss platforms.
Truepill Pricing Analysis & Total Cost: What You Actually Pay
Independent pricing analysis of Truepill's B2B pharmacy infrastructure, consumer-facing costs, regulatory history, and how it compares to alternative telehealth pharmacy platforms.
Truepill: Who It's Best For and What to Know Before You Choose
An independent analysis of Truepill's B2B telehealth pharmacy infrastructure, who benefits most from platforms built on it, and the clinical and regulatory factors patients should weigh.
Viome Pricing Analysis: What You Actually Pay for Microbiome Testing and Supplements
Independent cost breakdown of Viome's microbiome testing kits and subscription supplements, with clinical evidence on whether the science justifies the price.
Vyleesi Cost: $850-$950 per Carton vs. Addyi Pricing
Vyleesi runs $850 to $950 per carton (about $215-$240 per dose), versus $800-$1,000 for brand Addyi or $30-$80 for generic flibanserin.
Can Crestor Cause Liver Damage? How to Read the Whole Pattern
Crestor can raise transaminases and rarely cause serious injury. Learn what the current rosuvastatin label says and how clinicians read the full liver pattern.
Can Lipitor Cause Liver Damage? Read the Signal, Not Just ALT
Lipitor can raise liver enzymes and very rarely cause serious injury. See the current atorvastatin label, dose signal, symptom pattern, and monitoring logic.
Can You Take Eliquis and Ibuprofen Together?
Combining Eliquis (apixaban) with ibuprofen raises bleeding risk significantly. Learn why this interaction matters, what the evidence shows, and which pain relievers are safer alternatives.
Does Blue Cross Blue Shield Cover Eliquis?
Find out if Blue Cross Blue Shield covers Eliquis (apixaban), including formulary tiers, copay ranges, prior authorization requirements, and how to lower your out-of-pocket cost.
Does Kaiser Permanente Cover Eliquis?
Learn whether Kaiser Permanente covers Eliquis (apixaban), what tier it falls under, prior authorization requirements, copay costs, and how to get coverage approved.
Does Metoprolol Cause Hair Loss?
Hair loss has been reported with metoprolol. Understand the evidence, other causes of shedding, formulation questions and how to discuss a treatment change.
Sylvester Stallone, Testosterone, and HGH: What the Public Record Proves
A source-by-source audit of Sylvester Stallone's public testosterone and HGH record—and the doses, diagnosis, current use, and physique claims it cannot establish.
How to Safely Stop Cialis (Tadalafil): A Clinician-Backed Discontinuation Protocol
Evidence-based guide to safely discontinuing tadalafil (Cialis) for ED or BPH, including tapering considerations, rebound risks, and when to consult your prescriber.
Cialis (Tadalafil) Food and Supplement Interactions: What to Avoid and Why
A guide to tadalafil food and supplement interactions, including grapefruit, alcohol, nitrates, and common supplements that alter PDE5 inhibitor pharmacokinetics.
Cialis (Tadalafil) Geriatric Monitoring: What Clinicians and Patients Over 65 Need to Track
Evidence-based monitoring guide for tadalafil (Cialis) use in adults 65 and older, covering renal function, blood pressure, drug interactions, falls risk, and deprescribing timelines.
Cialis (Tadalafil) Manufacturing, Supply, and Shortage History
A clinical overview of tadalafil manufacturing origins, generic entry, FDA shortage events, and current supply chain status for Cialis and its generic equivalents.
Cialis Overdose and Accidental Excess Dose: What to Do and What to Expect
A guide to tadalafil (Cialis) overdose management, including symptoms, treatment protocols, pharmacokinetics at supratherapeutic doses, and when to seek emergency care.
CJC-1295 Mechanism of Action: Full Pathway From Injection to IGF-1 Output
How CJC-1295 acts on the GHRH receptor to raise growth hormone, with IGF-I up for 9 to 11 days after one DAC injection in healthy adults.
CJC-1295 Monitoring: What the Human Studies Measured
No monitoring schedule has been established for CJC-1295. The DAC-form trials in healthy adults measured GH, IGF-I and side effects.
CJC-1295 Pharmacogenomics: How Genetic Variability Affects Growth Hormone Response
How pharmacogenomics and genetic variants in GHRHR, GH1, IGF1, and SOCS genes shape individual responses to CJC-1295 modified GRF. Evidence-based guide for clinicians and patients.
5-α Reductase Inhibitors Class Overview Monograph
Clinical monograph covering the 5-α reductase inhibitor drug class, including finasteride and dutasteride. Mechanism, pharmacokinetics, landmark trials, dosing, adverse effects, and prescribing considerations for BPH and androgenetic alopecia.
Aromatase Inhibitors Class Overview Monograph
Clinical monograph covering the aromatase inhibitor drug class: anastrozole, letrozole, and exemestane. Mechanism, dosing, trials, adverse effects, monitoring, and off-label use in men.
Biguanides Monitoring Bundle: Lab Schedules, Thresholds, and Clinical Decision Points
A prescriber-level monitoring guide for biguanides (metformin). Covers baseline labs, renal surveillance, vitamin B12 screening, lactic acidosis risk stratification, and contrast-hold protocols.
Bisphosphonates Class Overview Monograph
A prescriber-level monograph covering bisphosphonate pharmacology, dosing, efficacy data, adverse effects, monitoring, and clinical decision points for osteoporosis management.
Bisphosphonates Monitoring Bundle: Labs, Imaging, and Follow-Up Schedules for Prescribers
A prescriber-level guide to bisphosphonate monitoring, covering baseline labs, on-treatment surveillance, renal function tracking, dental screening, and when to consider a drug holiday.
Bisphosphonates Special-Populations Summary: Prescribing Across Renal, Geriatric, Pediatric, and Reproductive Subgroups
A clinician-focused summary of bisphosphonate prescribing in special populations including renal impairment, geriatric patients, premenopausal women, pediatric use, and pregnancy. Includes dose adjustments, monitoring, and contraindications.
Copper Peptides Drug-Drug Interaction Table: A Prescriber and Pharmacist Reference
Complete drug-drug interaction (DDI) table for the copper peptides class, centered on GHK-Cu. Covers topical and systemic formulations, chelation conflicts, retinoid co-use, and monitoring guidance for polypharmacy patients.
Copper Peptides Monitoring Bundle: Lab Panels, Schedules, and Clinical Thresholds for GHK-Cu Prescribers
Evidence-based monitoring protocol for copper peptide (GHK-Cu) therapy covering baseline labs, ongoing surveillance intervals, serum copper and ceruloplasmin targets, hepatic panels, and discontinuation criteria for prescribing clinicians.
DPP-4 Inhibitor Adverse-Event Management: Clinical Protocols for Prescribers
Evidence-based protocols for identifying, grading, and managing adverse events associated with DPP-4 inhibitors (sitagliptin, saxagliptin, linagliptin, alogliptin) in type 2 diabetes.
DPP-4 Inhibitors Class Overview Monograph
A clinician-level monograph covering the DPP-4 inhibitor drug class: mechanism, pharmacokinetics, CV outcomes trials, renal dosing, place in therapy, and prescribing guidance for sitagliptin, saxagliptin, linagliptin, alogliptin, and vildagliptin.
DPP-4 Inhibitors Monitoring Bundle: Labs, Timelines, and Clinical Checkpoints
A prescriber-level guide to the monitoring bundle for DPP-4 inhibitors (gliptins), covering baseline labs, follow-up intervals, renal dose adjustments, and safety surveillance for sitagliptin, saxagliptin, linagliptin, and alogliptin.
Systemic Estrogens Drug-Drug Interaction Table
A clinician-focused drug-drug interaction reference for systemic estrogens, covering CYP3A4 inducers, thyroid binding changes, anticoagulant effects, and management strategies for estradiol, conjugated estrogens, and ethinyl estradiol.
Systemic Estrogens Titration and Tapering Algorithms
Evidence-based titration and tapering protocols for systemic estrogen therapy in menopausal hormone replacement, including oral estradiol, transdermal patches, and conjugated estrogens. Written for prescribers and dispensing pharmacists.
GHRH Analogs Billing and Prior-Authorization Playbook
A prescriber-level guide to billing codes, payer policies, prior-authorization workflows, and appeals strategies for GHRH analog peptides including sermorelin, tesamorelin, and CJC-1295.
GIP/GLP-1 Dual Agonists: Special-Populations Prescribing Summary
Evidence-based prescribing guide for tirzepatide and other GIP/GLP-1 dual agonists in renal impairment, hepatic disease, older adults, adolescents, pregnancy, and heart failure with preserved ejection fraction.
Triple Agonists (GLP-1/GIP/Glucagon) Special-Populations Summary
Clinician-focused review of prescribing triple agonists like retatrutide in special populations including renal impairment, hepatic disease, older adults, pregnancy, and adolescents.
GLP-1 Receptor Agonists: Class Overview Monograph
A prescriber-level monograph covering GLP-1 receptor agonist pharmacology, approved indications, landmark trial data, dosing, adverse effects, and clinical selection guidance.
GLP-1 Receptor Agonists Drug-Drug Interaction Table
Label-based interaction guide for Wegovy, Foundayo and tirzepatide covering insulin hypoglycemia, delayed gastric emptying, contraceptives and CYP3A4.
GH Secretagogues Drug-Drug Interaction Table
Complete drug-drug interaction (DDI) reference for growth hormone secretagogues including ipamorelin, CJC-1295, tesamorelin, sermorelin, and MK-677. Written for prescribers and pharmacists.
Healing Peptides (BPC-157 / TB-500) Adverse-Event Management Protocols
Evidence-based adverse-event management protocols for BPC-157 and TB-500 healing peptides, including grading scales, clinical decision points, dose modifications, and when to discontinue therapy.
Healing Peptides (BPC-157 / TB-500) Drug-Drug Interaction Table
Clinician-focused drug-drug interaction reference for BPC-157 and TB-500 healing peptides, covering known pharmacologic interactions, CYP considerations, and co-prescribing precautions.
Healing Peptides (BPC-157 / TB-500): Special-Populations Prescribing Summary
Evidence-based special-populations guide for BPC-157 and TB-500 (thymosin beta-4). Covers renal impairment, hepatic dysfunction, pediatrics, geriatrics, pregnancy, lactation, and immunocompromised patients at MD/PharmD level.
Meglitinides Drug-Drug Interaction Table: A Prescriber and Pharmacist Reference
Complete drug-drug interaction table for meglitinides (repaglinide, nateglinide) covering CYP2C8, CYP3A4, CYP2C9, and OATP1B1 interactions with clinical management recommendations.
Meglitinides: Selecting the Right Agent Within the Class
A clinician-focused comparison of repaglinide vs nateglinide covering pharmacokinetics, efficacy, renal dosing, drug interactions, and evidence-based selection criteria for prandial glucose control.
NAD Precursors Class Overview Monograph
Clinical monograph covering the NAD precursor drug class, including nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), niacin, and nicotinamide. Mechanisms, pharmacokinetics, trial data, dosing, safety, and prescribing considerations.
NAD Precursors Monitoring Bundle: Lab Panels, Timelines, and Clinical Checkpoints for Prescribers
A prescriber-level monitoring bundle for NAD precursor therapy (NMN, NR, niacin, niacinamide) covering baseline labs, follow-up intervals, safety signals, and dose-adjustment triggers.
PDE5 Inhibitors Billing and Prior-Authorization Playbook
A clinician-facing guide to billing codes, prior-authorization workflows, and payer strategies for PDE5 inhibitors including sildenafil, tadalafil, vardenafil, and avanafil.
PDE5 Inhibitors Drug-Drug Interaction Table
Complete drug-drug interaction (DDI) reference for PDE5 inhibitors including sildenafil, tadalafil, vardenafil, and avanafil. CYP3A4 interactions, nitrate contraindications, alpha-blocker timing, and dose adjustments for prescribers.